Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

14.59
-0.3250-2.18%
Volume:413.11K
Turnover:6.11M
Market Cap:1.15B
PE:-8.07
High:15.50
Open:15.22
Low:14.42
Close:14.91
52wk High:36.26
52wk Low:2.86
Shares:78.66M
Float Shares:53.14M
Volume Ratio:0.24
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8064
EPS(LYR):-2.2041
ROE:-59.22%
ROA:-34.41%
PB:3.73
PE(LYR):-6.62

Loading ...

Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report